SELE and thalassemia: This systematic review and meta-analysis identifies ICAM-1, VCAM-1, E-selectin, P-selectin, and ET-1 as biomarkers for assessing cardiovascular risk in thalassemia patients, underscoring their potential for early detection and targeted interventions in clinical practice.